- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06823310
Antibiofilm Activity of Chitosan Nanoparticles Incorporated Into Clear Aligners
Antibiofilm Activity of Directly Printed Orthodontic Clear Aligners with Incorporated Chitosan Nanoparticles (A Randomized Clinical Trial)
The use of orthodontic appliances and equipment has dramatically increased over the past few decades, mainly due to improvements in materials and manufacturing processes that have paved the way for improved treatments .
The preference for aligner treatment and the increase in its prevalence can be attributed to patient demand for "invisible" treatments and the limitations of conventional fixed orthodontics . Direct 3D printing offers the possibility of creating highly precise clear aligners with soft edges, digitally designed and identically reproduced for an entire set of treatment aligners. These provide a better fit, higher efficacy, and reproducibility .
Clear aligner treatment demonstrated promising results in terms of controlling plaque index, gingival health, and the prevalence of white spot lesions. Nevertheless, grooves, ridges, microcracks, and abrasions on the aligner surface provide a prime environment for bacterial adherence and the development of plaque biofilms. Adding chitosan, a minimally toxic agent with antibacterial properties and the ability to reduce enamel demineralization, to 3D-printed aligner resin materials may decrease the incidence of WSLs . Currently, there is limited research on including nanoparticles in aligners' material for microbe inhibition and, to the best of our knowledge, none of the research has assessed and compared the effect of adding chitosan to an aligner's resin.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The use of orthodontic appliances and equipment has dramatically increased over the past few decades, mainly due to improvements in materials and manufacturing processes that have paved the way for improved treatments .
The preference for aligner treatment and the increase in its prevalence can be attributed to patient demand for "invisible" treatments and the limitations of conventional fixed orthodontics. Direct 3D printing offers the possibility of creating highly precise clear aligners with soft edges, digitally designed and identically reproduced for an entire set of treatment aligners. These provide a better fit, higher efficacy, and reproducibility.
Clear aligner treatment demonstrated promising results in terms of controlling plaque index, gingival health, and the prevalence of white spot lesions. Nevertheless, grooves, ridges, microcracks, and abrasions on the aligner surface provide a prime environment for bacterial adherence and the development of plaque biofilms. A combination of mechanical and chemical methods seem to be a successful approach for removing plaque biofilm from aligners whilst preventing pigment adsorption.
Orthodontic appliances change the ecological environment of the oral cavity, resulting in a significant increase in the number of cariogenic bacteria such as Streptococcus mutans (S. mutans). The imbalance in oral homeostasis can lead to enamel demineralization, periodontitis and other bacteria-related adverse effects of orthodontic treatment. According to evidence-based clinical assessments, once enamel demineralization is formed it is difficult to be fully reversed using currently available remineralizing agents. Thus, several antibacterial strategies have been used clinically to prevent enamel demineralization, including antibacterial mouthwashes and toothpastes. However, these conventional interventions are largely dependent on perfect compliance from the patients, which most of the times does not occur.
Chitosan nanoparticles have a wide range of applications and have long been employed with or without other substances and techniques to increase their functionality .
Adding chitosan, a minimally toxic agent with antibacterial properties and the ability to reduce enamel demineralization, to 3D-printed aligner resin materials may decrease the incidence of WSLs . Currently, there is limited research on including nanoparticles in aligners' material for microbe inhibition and, to the best of our knowledge, none of the research has assessed and compared the effect of adding chitosan to an aligner's resin . A recent study carried out by Taher and Rasheed in 2023 added chitosan nanoparticles at different concentrations (2%, 3%, and 5% w/w) to directly 3D-printed clear aligner resin and assessed its anti-biofilm activity (on Streptococcus mutans bacteria categorized as one of the most virulent bacteria to cause enamel lesions), degree of conversion, accuracy, deflection force, and tensile strength. Additionally, cytotoxicity has been assessed using tissue cultures of mice fibroblasts and embryonic cells of chitosan (2%, 3%, and 5% w/w). The results of this essay showed that all used concentrations were non cytotoxic to living cells. It was found that there was a notable reduction in bacterial colonies when the resin was incorporated with 3% and 5% chitosan nanoparticles. No significant changes in the cytotoxicity or accuracy were detected and it was concluded that integrating biocompatible chitosan nanoparticles into the resin can add an anti-biofilm element to an aligner without compromising the material's particular biological, mechanical, and physical qualities at specific concentrations.
As the previous study was carried out in vitro, this study aims at assessing the effect of in vivo aging on the anti-biofilm and anti-microbial activity of chitosan incorporated into directly printed clear aligner resin.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Al-Resafa
-
Baghdad, Al-Resafa, Iraq, 1011
- College of Dentistry, University of Baghdad
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Subjects falling in the age group of 18-28 years with mild malocclusion
- Full permanent dentition except for third molars
- Plaque score and Bleeding on probing should be less than 10% (O'Leary et al., 1972)
- No previous history of para-functional habits
Exclusion Criteria:
any criteria not mentioned above
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Control
control directly printed orthodontic clear aligners without chitosan nanoparticles
|
Directly printed orthodontic clear aligner without any additions
|
|
Experimental: chitosan
Directly printed orthodontic clear aligners with chitosan nanoparticles
|
Adding chitosan nanoparticles to directly printed orthodontic clear aligners in vivo to enhance anti- microbial activity against streptococcus mutans.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Antimicrobial properties of chitosan nanoparticles incorporated into directly 3D printed clear orthodontic aligner will be assessed by using antibiofilm assay
Time Frame: 2 weeks
|
The main outcome of this study is yo determine the antimicrobial effect of chitosan nanoparticles directly added to 3D printed clear aligners against Streptococcus mutans.
This will be conducted by using antibiofilm activity test at baseline, 1 week, and 2 weeks following wearing conventional and chitosan-incorporated clear aligners.
From each device retrieved from the patients at these timepoints, a 5mm diameter disc will be cut from the labial aspect of the devices.
These discs will be cultured overnight in a broth containing equal number of S. mutans bacteria.
After 24 h, the number of vital bacteria and the biomass will be measured to determine the antibiofilm activity of chitosan-incorporated devices vs control.
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported questionnaire about satisfaction of wearing clear aligner (control and experimental)
Time Frame: 2 weeks
|
To asses perceived patients outcome i.e., degree of satisfaction by using a questionnaire designed for this purpose about wearing both devices (control and experimental).
The questionnaire consists of two sections.
The first section is dedicated for collecting demographic and lifestyle variables.
The second section is designed to assess the degree of satisfaction by answering close-end questions.
Each positive response will be scored as "1" while negative response will be scored "0".
The sum of these responses will represent the overall satisfaction for each patient.
|
2 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1015425
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malocclusion, Angle Class I
-
Hesham Nabil Ali Al-QamhawyAl-Azhar UniversityRecruitingBimaxillary Protrusion | Malocclusion, Angle Class II, Division 1 | Class I MalocclusionEgypt
-
Bezmialem Vakif UniversityPEBS DENTAL CLINICRecruitingClass II Div 1 Malocclusion | Class III Malocclusion | Class II Division 2 Malocclusion | Class I MalocclusionTurkey (Türkiye)
-
State University of New York at BuffaloCompletedDental Malocclusion | Crowding, Tooth | Angle Class II | Angle Class IUnited States
-
Can Tho University of Medicine and PharmacyCompletedAngle Class IVietnam
-
Can Tho University of Medicine and PharmacyCompleted
-
Postgraduate Institute of Dental Sciences RohtakCompleted
-
Mersin UniversityCompletedCrowding, Tooth | Angle's Class I MalocclusionTurkey
-
AL YousefKing Abdullah International Medical Research CenterUnknownMalocclusion, Angle Class I | Malocclusion; Angle Class II Division 1Saudi Arabia
-
Al-Azhar UniversityRecruitingOrthodontic Tooth Movement | Class I Malocclusion | Maxillary PrognathismEgypt
-
Cairo UniversityRecruiting
Clinical Trials on Control (Standard treatment)
-
Kırıkkale UniversityCompletedRheumatoid Arthritis | Mobile ApplicationTurkey (Türkiye)
-
University of Castilla-La ManchaNot yet recruitingMultiple Sclerosis | Pelvic Floor DisorderSpain
-
Istanbul Medeniyet UniversityCompletedFibromyalgia | Exercise | Fibromyalgia (FM) | Syndrome PainTurkey
-
Cairo UniversityCompletedCerebral Palsy Spastic HemiplegicEgypt
-
TC Erciyes UniversityCompleted
-
Stanford UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Japet Medical DevicesUniversity Hospital, Clermont-Ferrand; Hôpital CochinRecruitingLow Back PainFrance
-
Hacettepe UniversityRecruiting
-
Ankara Yildirim Beyazıt UniversityUniverstiy of Health Sciences - Gülhane Faculty of Health SciencesRecruitingShoulder Pain | Scapular DyskinesisTurkey
-
kewen Chen,MDActive, not recruitingKidney Transplantation Recipients | Proteinuria PatientsChina